VKTX stock is trending due to positive results from Viking Therapeutics' obesity drug trial. The investigational treatment demonstrated significant weight loss in participants, exceeding placebo effects and showing no plateau by week 33.
Get the full breakdown — why it matters, background context, and what comes next.
Read Full Analysis